Halpin David M G, Vogelmeier Claus F, Agusti Alvar
University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, United Kingdom.
Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Member of the German Center for Lung Research (DZL), Philipps-University Marburg, Marburg, Germany.
Am J Physiol Lung Cell Mol Physiol. 2021 Nov 1;321(5):L978-L982. doi: 10.1152/ajplung.00386.2021. Epub 2021 Sep 29.
Early in the COVID pandemic there were concerns about the outcomes for patients with COPD who developed COVID-19. Although the pandemic has made the diagnosis and routine management of COPD more difficult, the risk of patients developing COVID or of having poor outcomes is less than anticipated and there have been some unexpected findings that may lead to significant improvements in the management of COPD in future.
在新冠疫情初期，人们对慢性阻塞性肺疾病（COPD）患者感染新冠病毒后的预后情况表示担忧。尽管疫情使慢性阻塞性肺疾病的诊断和常规管理变得更加困难，但患者感染新冠病毒或预后不良的风险低于预期，并且出现了一些意外发现，这些发现可能会在未来显著改善慢性阻塞性肺疾病的管理。
